FundamentalVR, a London-based virtual reality (VR) training, and data analysis technology startup, today announced a three-year strategic partnership with Mayo Clinic to co-develop new VR simulations leveraging haptic (sense of touch) technology for general surgical procedures, patient-specific modeling and emerging interfaces for robotic surgery.Additional $1.4M in FundingIn addition, the company has raised an additional $1.4 million in funding from existing investor Tern Plc. The company plans
Read More
Mayo Clinic Researchers Develop Genetics-based Prognostic Tool for Myelodysplastic Syndrome
Mayo Clinic researchers have developed a new genetics-based prognostic tool for myelodysplastic syndrome, according to their findings are published in the October print issue of Mayo Clinic Proceedings.Researcher Dr. Tefferi and collaborators from National Taiwan University Hospital in Taipei, Taiwan, examined gene mutations and their effect on survival in 685 patients with myelodysplastic syndrome. Researchers identified a favorable gene mutation, SF3B1, and unfavorable gene mutations, ASXL1
Read More
Mayo Clinic to Explore Use Cases of Blockchain-based EHRs
Medicalchain, a UK-based startup using blockchain technology to secure store EHRs securely has signed a joint development agreement with Mayo Clinic to explore the value of blockchain in healthcare. As part of the joint development agreement, both organizations will work together to develop use cases utilizing blockchain-based EHRs. This agreement comes after months of discussions between Mayo Clinic and Medicalchain on the potential benefits blockchain technology can bring to
Read More
Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel
Researchers at Exact Sciences Corp. and Mayo Clinic announced significant progress toward developing a panel of novel, blood-based, DNA biomarkers that could accurately detect hepatocellular carcinoma (HCC), the most common cancer that originates in the liver. The researchers detailed their findings during a presentation today at Digestive Disease Week.Using DNA extracted from the blood samples of 244 people, including 95 diagnosed across all stages of HCC, 51 with cirrhosis, and 98 healthy
Read More
Cytox Collaborates with Mayo Clinic to Develop New Algorithms to Evaluate Genetic Based Approaches for Assessing Alzheimer’s Risk
Cytox, a precision medicine company focused on commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s has entered into a research collaboration with Mayo Clinic to test current and develop new proprietary algorithms relating to the diagnosis and prognosis of Alzheimer’s disease. Under the agreement Cytox will assess genetic risk for developing Alzheimer’s disease using its current commercially available approaches developed to run on the
Read More
Mayo Clinic Partners With Orbita to Transform Patient Journey Through Voice First Experience
Orbita, Inc., a provider of digital experience management solutions for voice and conversational AI technologies in health and wellness applications, and Mayo Clinic have formed a relationship to deliver Mayo Clinic health and wellness content to help transform the patient journey through education, engagement and improved quality of care. The partnership between Orbita’s powerful voice platform and Mayo’s leading content gives organizations the ability to reach, engage and empower audiences in
Read More
SkylineDx Inks Partnership With Mayo Clinic to Develop Diagnostic Tests for Melanoma
SkylineDx, a Netherland-based commercial-stage biotech company has inked a joint development agreement with with Mayo Clinic to develop novel diagnostic tests which will improve clinical decision making for melanoma patients. For SkylineDx, the collaboration with the renowned Mayo Clinic is an important milestone as it allows the company to develop new diagnostic tests and extend its product offering for a broader group of patients and clinicians.The knowledge and experience of SkylineDx in the
Read More
Mayo Clinic, sphingotec Collaborate for Evaluation & Use of Biomarkers to Improve Diagnosis
sphingotec GmbH , a biotechnology company that develops biomarkers for the detection and management of diseases, has recently signed an agreement with Mayo Clinic to collaborate on the evaluation and use of several biomarkers that may improve the diagnosis of certain disease states, including kidney disease, breast cancer, sepsis, and cardiovascular disease.As part of the agreement, Mayo Clinic will evaluate the biomarkers proenkephalin (penKid) and three others for research and potential
Read More
Mayo Clinic, Oxford NHS Foundation Trust Partner to Advance Medical Research
Mayo Clinic, the University of Oxford, and Oxford University Hospitals NHS Foundation Trust have signed a partnership agreement to drive advances in medical research and patient care. Potential areas for collaboration include research projects, educational interactions and endeavors, practice pilots to focus on leading improvements in quality, integration and outcomes delivered, and the exchange of resources to support research, practice and educational activities.As part of the partnership,
Read More
Mayo Clinic Teams Up with NDSC to Develop CareSelect Lab for EHR-Integrated Medical Guidelines
Mayo Clinic has announced a new partnership with National Decision Support Company (NDSC) to develop CareSelect Lab, a real-time decision support tool to provide real-time medical guidance when ordering laboratory tests. The tool addresses common areas of laboratory test mis-utilization at the EHR point-of-order entry,CareSelect Lab integrates with a hospital’s electronic health record (EHR) and is delivered via NDSC’s CareSelect™ Platform — the same platform that drives NDSC’s
Read More